Glucose-Dependent Insulinotropic Polypeptide Inhibits AGE-Induced NADPH Oxidase-Derived Oxidative Stress Generation and Foam Cell Formation in Macrophages Partly via AMPK Activation.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
08 Sep 2024
Historique:
received: 03 08 2024
revised: 02 09 2024
accepted: 06 09 2024
medline: 14 9 2024
pubmed: 14 9 2024
entrez: 14 9 2024
Statut: epublish

Résumé

Glucose-dependent insulinotropic polypeptide (GIP) of the incretin group has been shown to exert pleiotropic actions. There is growing evidence that advanced glycation end products (AGEs), senescent macromolecules formed at an accelerated rate under chronic hyperglycemic conditions, play a role in the pathogenesis of atherosclerotic cardiovascular disease in diabetes. However, whether and how GIP could inhibit the AGE-induced foam cell formation of macrophages, an initial step of atherosclerosis remains to be elucidated. In this study, we address these issues. We found that AGEs increased oxidized low-density-lipoprotein uptake into reactive oxygen species (ROS) generation and

Identifiants

pubmed: 39273671
pii: ijms25179724
doi: 10.3390/ijms25179724
pii:
doi:

Substances chimiques

Glycation End Products, Advanced 0
NADPH Oxidases EC 1.6.3.-
AMP-Activated Protein Kinases EC 2.7.11.31
Reactive Oxygen Species 0
Cyclin-Dependent Kinase 5 EC 2.7.11.1
Gastric Inhibitory Polypeptide 59392-49-3
CD36 Antigens 0
CDK5 protein, human EC 2.7.11.22
oxidized low density lipoprotein 0
Lipoproteins, LDL 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Association for Diabetes Education and Care
ID : 2021-YNG-002
Organisme : Japan Society for the Promotion of Science
ID : 20K07075
Organisme : Japan Society for the Promotion of Science
ID : 24K09316
Organisme : Research Grant Award 2022 from the Japanese Society of Anti-Aging Medicine
ID : 2022-2

Auteurs

Michishige Terasaki (M)

Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Graduate School of Medicine, Showa University, 1-5-8 Shinagawa, Tokyo 142-8666, Japan.

Hironori Yashima (H)

Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Graduate School of Medicine, Showa University, 1-5-8 Shinagawa, Tokyo 142-8666, Japan.

Yusaku Mori (Y)

Anti-Glycation Research Section, Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Graduate School of Medicine, Showa University, 1-5-8 Shinagawa, Tokyo 142-8666, Japan.

Tomomi Saito (T)

Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Graduate School of Medicine, Showa University, 1-5-8 Shinagawa, Tokyo 142-8666, Japan.

Naoto Inoue (N)

Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Graduate School of Medicine, Showa University, 1-5-8 Shinagawa, Tokyo 142-8666, Japan.

Takanori Matsui (T)

Department of Bioscience and Biotechnology, Fukui Prefectural University, Eiheiji, Fukui 910-1195, Japan.

Naoya Osaka (N)

Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Graduate School of Medicine, Showa University, 1-5-8 Shinagawa, Tokyo 142-8666, Japan.

Tomoki Fujikawa (T)

Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Graduate School of Medicine, Showa University, 1-5-8 Shinagawa, Tokyo 142-8666, Japan.

Makoto Ohara (M)

Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Graduate School of Medicine, Showa University, 1-5-8 Shinagawa, Tokyo 142-8666, Japan.

Sho-Ichi Yamagishi (SI)

Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Graduate School of Medicine, Showa University, 1-5-8 Shinagawa, Tokyo 142-8666, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH